{
    "2020-08-19": [
        [
            {
                "time": "",
                "original_text": "药明系第三家上市公司：药明巨诺能否重演药明康德传奇？",
                "features": {
                    "keywords": [
                        "药明系",
                        "上市公司",
                        "药明巨诺",
                        "药明康德"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-08-19",
                "original_text": "药明康德(02359)8月19日购回及注销89.796万股限制性A股股票",
                "features": {
                    "keywords": [
                        "药明康德",
                        "购回",
                        "注销",
                        "限制性A股股票"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "瑞银：上调药明康德(02359)目标价至137港元，维持“买入”评级",
                "features": {
                    "keywords": [
                        "瑞银",
                        "上调",
                        "目标价",
                        "药明康德",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：如何看待近期医药的回调？",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "回调"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业投资周报：保持定力紧抓优势赛道龙头 疫情股侧重长期影响和疫苗临床进展",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资周报",
                        "优势赛道",
                        "疫情股",
                        "疫苗",
                        "临床进展"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}